Kyrgyzstan plans major expansion of protected natural areas by 2035
Kyrgyzstan has unveiled plans to significantly expand its protected natural areas, bringing more high-altitude glaciers, mountain landscapes and st...
The Democratic Republic of Congo has begun administering Ebola vaccines to frontline workers as authorities race to contain the country's largest and deadliest outbreak of the virus.
The vaccination campaign was launched in Kisangani, the capital of Tshopo province, one of several regions affected by the outbreak.
Officials are initially focusing on healthcare workers and personnel involved in the Ebola response, who face the highest risk of exposure while treating patients and tracing infections.
Congolese authorities have opted to deploy the Ervebo vaccine, which proved effective during previous Ebola outbreaks caused by the Zaire strain of the virus. However, the current outbreak involves the Bundibugyo strain, for which no fully licensed vaccine is yet available.
Health Minister Roger Kamba said the decision was made to provide immediate protection to those on the front lines while researchers continue efforts to develop and test vaccines specifically designed for the current variant.
The latest outbreak has already become the most severe Ebola crisis the country has faced.
According to official figures released this week, more than 5,700 confirmed cases have been recorded, while the death toll has surpassed 2,700 people. The outbreak is concentrated in the eastern province of Ituri, although cases have spread to several other provinces.
Congo has experienced numerous Ebola outbreaks over the past decades, but health officials say the scale and lethality of the current epidemic have surpassed previous emergencies.
The rapid rise in infections has placed additional pressure on an already strained healthcare system, particularly in remote areas where access to medical facilities remains limited.
Alongside the emergency vaccination effort, international partners are accelerating research into vaccines tailored to the Bundibugyo strain.
The Coalition for Epidemic Preparedness Innovations (CEPI) announced new financial support for Egypt-based pharmaceutical company Minapharm Group to advance an experimental Bundibugyo Ebola vaccine into human clinical trials in Africa.
The funding, worth up to $16.5 million, is intended to help move the candidate vaccine through the next stage of development as scientists work to find longer-term solutions to the outbreak.
CEPI said the Minapharm project is one of several vaccine programmes being supported in response to the crisis. The organisation has now backed five Bundibugyo Ebola vaccine candidates as part of a broader effort to expand protection against a disease that continues to pose a major public health threat in Central Africa.
Public health experts say the vaccination campaign represents an important step in protecting healthcare workers, but stress that vaccinations alone will not end the outbreak.
Containment efforts also depend on rapid case detection, treatment, contact tracing and community engagement, particularly in affected regions where mistrust of health authorities can complicate response measures.
With infections continuing to rise, Congolese authorities and international health partners face mounting pressure to slow the spread of the virus and prevent the outbreak from expanding further across the region.
For now, officials hope the combination of emergency vaccinations, enhanced surveillance and ongoing vaccine research can help turn the tide against one of the most serious Ebola outbreaks ever recorded.
Despite losing his bloc's majority in Israel's 120-seat Knesset in a hotly contested election, Prime Minister Benjamin Netanyahu has managed to remain in the lead after 70 per cent of votes were tallied on Wednesday. Figures are subject to change as counting continues.
Russia and Ukraine have begun a regional ceasefire to allow the start of a humanitarian effort in the Russian-occupied town of Oleshky, both sides said on Tuesday, but they continue strikes elsewhere, including the Ukrainian capital of Kyiv.
Russian strikes hit several parts of Ukraine overnight, injuring at least six people and targeting energy and port infrastructure, as President Volodymyr Zelenskyy said U.S. warnings about imminent Russian ballistic missile attacks had resumed.
Nearly two years after the 20 October 2024 parliamentary elections, Iraq’s Kurdistan Region remains without a cabinet. The Kurdistan Democratic Party (KDP) won 39 of 100 seats and the Patriotic Union of Kurdistan (PUK) 23, leaving neither able to govern alone.
The Pentagon is prepared to launch potentially major military operations against Iran within 96 hours of receiving an order from U.S. President Donald Trump, with sufficient forces already deployed in the Middle East, according to a CNN report.
U.S. President Donald Trump said early Wednesday that a meeting between Russian President Vladimir Putin and Ukrainian President Volodymyr Zelenskyy would be arranged soon, while leaving the door open to further U.S. strikes on Iran following next week's midterm elections.
At least 35 people have been killed after two high-speed trains collided in Spain on Wednesday, in the second deadly rail disaster in less than a year on a major route linking Madrid with the southern Andalusia region.
Azerbaijan has called for stronger international cooperation against corruption and cross-border financial crime as senior officials from the Organization of Islamic Cooperation (OIC) gathered in Baku on Wednesday, 28 October.
Qatari mediators have presented Iran with a new proposal to end the war with the U.S. and Israel, with Tehran expected to respond by the end of the week, according to an official briefed on the negotiations.
Despite losing his bloc's majority in Israel's 120-seat Knesset in a hotly contested election, Prime Minister Benjamin Netanyahu has managed to remain in the lead after 70 per cent of votes were tallied on Wednesday. Figures are subject to change as counting continues.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment